Genmab | GEN - Interest Income


Genmab reported DKK25M in Interest Income for its fiscal quarter ending in June of 2025.





Interest Income Change Date
Agios Pharmaceuticals USD 13.37M 1.14M Sep/2025
Almirall EUR 2.71M 580K Dec/2025
Amarin USD 3.37M 3.37M Dec/2024
argenx SE USD 42.7M 4.3M Sep/2025
AstraZeneca USD 85M 17M Sep/2025
Bayer EUR 130M 38M Sep/2025
BioMarin Pharmaceutical USD 17.85M 973K Sep/2025
Exelixis USD 15.92M 867K Sep/2025
Fresenius Medical Care EUR 13.62M 5.54M Dec/2025
Galapagos EUR 12.56M 4.66M Mar/2025
Genmab DKK 25M 8M Jun/2025
GlaxoSmithKline GBP 26M 24M Sep/2025
GN Store Nord DKK 69M 52M Jun/2025
GRIFOLS EUR 9.56M 4.5M Jun/2025
Hikma Pharmaceutical USD 4M 0 Dec/2024
Insmed USD 765K 55K Sep/2024
Merck EUR 27M 10M Sep/2025
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Sanofi EUR 114M 38M Sep/2025